Bariatric surgery is an effective treatment for morbid obesity

Netherlands Journal of Medicine

Volumn 71, Issue 1, 2013, Pages 4-9

  Schigt, A ^a   Gerdes, V E A ^b   Cense, H A ^c   Berends, F J ^d   van Dielen, F M H ^e   Janssen, I ^d   van der Laar, A ^b   van Wagensveld, B A ^f   Romijn, J A ^a   Serlie, M J ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b SLOTERVAART HOSPITAL   (Netherlands)

^c RED CROSS HOSPITAL   (Netherlands)

^d RIJNSTATE HOSPITAL   (Netherlands)

^e MÁXIMA MEDICAL CENTER   (Netherlands)

^f ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

Author keywords

Bariatric surgery; Morbid obesity; Treatment

Indexed keywords

ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

BARIATRIC SURGERY; COMORBIDITY; DISEASE ASSOCIATION; HEALTH CARE; HEALTH CARE COST; HUMAN; HYPERTENSION; INCIDENCE; ISCHEMIC HEART DISEASE; LAPAROSCOPIC SURGERY; MORBID OBESITY; MORTALITY; NETHERLANDS; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTOPERATIVE COMPLICATION; PREVALENCE; PSYCHOLOGICAL ASPECT; PUBLIC HEALTH; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; WEIGHT REDUCTION;

BARIATRIC SURGERY; HUMANS; OBESITY, MORBID; TREATMENT OUTCOME;

EID: 84874161412     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (58)

1. Swinburn BA, Sacks G, Hall KD, et al. The global obesity pandemic: shaped by global drivers and local environments. Lancet. 2011;378:804-14.
2. Wang YC, McPherson K, Marsh T, Gortmaker SL, Brown M. Health and economic burden of the projected obesity trends in the USA and the UK. Lancet. 2011;378:815-25.
3. Hall KD, Sacks G, Chandramohan D, et al. Quantification of the effect of energy imbalance on bodyweight. Lancet. 2011;378:826-37.
4. Gortmaker SL, Swinburn BA, Levy D, et al. Changing the future of obesity: science, policy, and action. Lancet. 2011;378:838-47.
5. WHO expert consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363:157-63.
6. Finucane MM, Stevens GA, Cowan MJ, et al. National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet. 2011;377:557-67.
7. Binsbergen van JJ. NHG-Standaard Obesitas-M95 (Full text: http:// nhg.artsennet.nl/kenniscentrum/k_richtlijnen/k_nhgstandaarden/ NHGStandaard/M95_std.htm). 2010.
8. Rucker D, Padwal R, Li SK, Curioni C, Lau DC. Long term pharmacotherapy for obesity and overweight: updated meta-analysis. BMJ. 2007;335:1194-9.
9. Maggard MA, Shugarman LR, Suttorp M, et al. Meta-analysis: surgical treatment of obesity. Ann Intern Med. 2005;142:547-59.
10. Sjostrom L, Peltonen M, Jacobson P, et al. Bariatric surgery and long-term cardiovascular events. JAMA. 2012;307:56-65.
11. Christou NV, Sampalis JS, Liberman M, et al. Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients. Ann Surg. 2004;240:416-23.
12. Brauw DM, Klaassen R, Jansen I. Bariatrische chirurgie vereist ervaring. Medisch Contact. 2009;43:1752-5.
13. Buchwald H, Oien DM. Metabolic/bariatric surgery Worldwide 2008. Obes Surg. 2009;19:1605-11.
14. Zembla. Slank in één dag (Link to television broadcast: http://zembla. vara.nl/Afleveringen.1973.0.html?&tx_ttnews[tt_news]=52091&cHash= c0e24f92c104c2a29eff3c6d8566de9f). 2011 Nov 11.
15. De Brauw M, Klaassen R, Van Wagensveld B, Janssen I, De Zoete JP, Van Ramshorst B. Slank in één dag. De Volkskrant, ingezonden artikel 2011 Dec 14;29.
16. Donini LM, Savina C, Castellaneta E, et al. Multidisciplinary approach to obesity. Eat Weight Disord. 2009;14:23-32.
17. Vignolo M, Rossi F, Bardazza G, et al. Five-year follow-up of a cognitivebehavioural lifestyle multidisciplinary programme for childhood obesity outpatient treatment. Eur J Clin Nutr. 2008;62:1047-57.
18. Van Polanen Petel V. Aandeel inwoners met ernstig overgewicht in Nederland lager dan in andere OESO-landen (Full text: http://www. cbs.nl/nl-NL/menu/themas/gezondheid-welzijn/publicaties/artikelen/ archief/2011/2011-3514-wm.htm). 2011 Nov 24.
19. Kemper H, Brug J, Mathus-Vliegen E, et al. Overgewicht en obesitas. 2003 Apr 28.
20. McPherson K, Marsh T, Brown M. Tackling Obesities: Future Choices-Modelling Future Trends in Obesity and the Impact on Health. 2007 Oct 1.
21. Sturm R, Ringel JS, Andreyeva T. Increasing obesity rates and disability trends. Health Aff (Millwood). 2004;23:199-205.
22. Willett WC, Dietz WH, Colditz GA. Guidelines for healthy weight. N Engl J Med. 1999;341:427-34.
23. Whitlock G, Lewington S, Sherliker P, et al. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet. 2009;373:1083-96.
24. van Gemert WG, Severeijns RM, Greve JW, Groenman N, Soeters PB. Psychological f unctioning o f m orbidly o bese p atients a fter s urgical treatment. Int J Obes Relat Metab Disord. 1998;22:393-8.
25. Quesenberry CP, Jr., Caan B, Jacobson A. Obesity, health services use, and health care costs among members of a health maintenance organization. Arch Intern Med. 1998;158:466-72.
26. Geertjes K. Gezondheid en zorg in cijfers 2007 (Full text: http:// www.cbs.nl/NR/rdonlyres/6C792CAC-CF11-4F5E-B25FA22BDA8F7502/ 0/2007c156pub.pdf). 2007.
27. Narbro K, Agren G, Jonsson E, Naslund I, Sjostrom L, Peltonen M. Pharmaceutical costs in obese individuals: comparison with a randomly selected population sample and long-term changes after conventional and surgical treatment: the SOS intervention study. Arch Intern Med. 2002;162:2061-9.
28. Polder J, Takken J, Meerding W, Kommer GJ, Stokx L. Kosten van Ziekten in Nederland (Full text: http://www.rivm.nl/bibliotheek/ rapporten/270751005.pdf). 2002.
29. Raad voor de Volksgezondheid en Zorg. Gezondheid en gedrag (Full text: http://rvz.net/uploads/docs/Advies_-_Gezondheid_en.pdf). 2002.
30. World Health Organization. Obesity: preventing and managing the global epidemic. 2000.
31. Centraal BegeleidingsOrgaan. Diagnostiek en behandeling van obesitas bij volwassenen en kinderen (Full text: http://www.cbo.nl/ Downloads/307/rl_obesitas_08.pdf). 2008.
32. Centraal BegeleidingsOrgaan. Diagnostiek en behandeling van obesitas bij volwassenen en kinderen. 2008.
33. Colquitt JL, Picot J, Loveman E, Clegg AJ. Surgery for obesity. Cochrane Database Syst Rev. 2009;(2):CD003641.
34. Sjostrom L, Lindroos AK, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351:2683-93.
35. Agren G, Narbro K, Naslund I, Sjostrom L, Peltonen M. Long-term effects of weight loss on pharmaceutical costs in obese subjects. A report from the SOS intervention study. Int J Obes Relat Metab Disord. 2002;26:184-92.
36. Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric Surgery versus Conventional Medical Therapy for Type 2 Diabetes. N Engl J Med. 2012 Mar 26.
37. Schauer PR, Kashyap SR, Wolski K, al. Bariatric Surgery versus Intensive Medical Therapy in Obese Patients with Diabetes. N Engl J Med. 2012 Mar 26.
38. Karlsson J, Taft C, Ryden A, Sjostrom L, Sullivan M. Ten-year trends in health-related quality of life after surgical and conventional treatment for severe obesity: the SOS intervention study. Int J Obes (Lond). 2007;31:1248-61.
39. Karlsson J, Sjostrom L, Sullivan M. Swedish obese subjects (SOS)--an intervention study of obesity. Two-year follow-up of health-related quality of life (HRQL) and eating behavior after gastric surgery for severe obesity. Int J Obes Relat Metab Disord. 1998;22:113-26.
40. Ryden A, Sullivan M, Torgerson JS, Karlsson J, Lindroos AK, Taft C. A comparative controlled study of personality in severe obesity: a 2-y follow-up after intervention. Int J Obes Relat Metab Disord. 2004;28:1485-93.
41. Cummings DE, Weigle DS, Frayo RS, et al. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med. 2002;346:1623-30.
42. Korner J, Bessler M, Cirilo LJ, et al. Effects of Roux-en-Y gastric bypass surgery on fasting and postprandial concentrations of plasma ghrelin, peptide YY, and insulin. J Clin Endocrinol Metab. 2005;90:359-65.
43. Tritos NA, Mun E, Bertkau A, Grayson R, Maratos-Flier E, Goldfine A. Serum ghrelin levels in response to glucose load in obese subjects post-gastric bypass surgery. Obes Res. 2003;11:919-24.
44. O'Brien PE. Bariatric surgery: mechanisms, indications and outcomes. J Gastroenterol Hepatol. 2010;25:1358-65.
45. Romy S, Donadini A, Giusti V, Suter M. Roux-en-Y gastric bypass vs gastric banding for morbid obesity: a case-matched study of 442 patients. Arch Surg. 2012;147:460-6.
46. Cancello R, Henegar C, Viguerie N, al. Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss. Diabetes. 2005;54:2277-86.
47. Tice JA, Karliner L, Walsh J, Petersen AJ, Feldman MD. Gastric banding or bypass? A systematic review comparing the two most popular bariatric procedures. Am J Med. 2008;121:885-93.
48. Gustavsson S, Westling A. Laparoscopic adjustable gastric banding: complications and side effects responsible for the poor long-term outcome. Semin Laparosc Surg. 2002;9:115-24.
49. Shi X, Karmali S, Sharma AM, Birch DW. A review of laparoscopic sleeve gastrectomy for morbid obesity. Obes Surg. 2010;20:1171-7.
50. DeMaria EJ, Pate V, Warthen M, Winegar DA. Baseline data from American Society for Metabolic and Bariatric Surgery-designated Bariatric Surgery Centers of Excellence using the Bariatric Outcomes Longitudinal Database. Surg Obes Relat Dis. 2010;6:347-55.
51. Buchwald H, Estok R, Fahrbach K, Banel D, Sledge I. Trends in mortality in bariatric surgery: a systematic review and meta-analysis. Surgery. 2007;142:621-32.
52. Flum DR, Belle SH, King WC, et al. Perioperative safety in the longitudinal assessment of bariatric surgery. N Engl J Med. 2009;361:445-54.
53. Turrentine FE, Hanks JB, Schirmer BD, Stukenborg GJ. The Relationship Between Body Mass Index and 30-Day Mortality Risk, by Principal Surgical Procedure. Arch Surg 2011 Nov 21.
54. DeMaria EJ, Murr M, Byrne TK, et al. Validation of the obesity surgery mortality risk score in a multicenter study proves it stratifies mortality risk in patients undergoing gastric bypass for morbid obesity. Ann Surg. 2007;246:578-82.
55. Higa KD, Boone KB, Ho T. Complications of the laparoscopic Roux-en-Y gastric bypass: 1,040 patients--what have we learned? Obes Surg. 2000;10:509-13.
56. Ballesta-Lopez C, Poves I, Cabrera M, Almeida JA, Macias G. Learning curve for laparoscopic Roux-en-Y gastric bypass with totally hand-sewn anastomosis: analysis of first 600 consecutive patients. Surg Endosc. 2005;19:519-24.
57. Heber D, Greenway FL, Kaplan LM, Livingston E, Salvador J, Still C. Endocrine and nutritional management of the post-bariatric surgery patient: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2010;95:4823-43.
58. Nederlandse Vereniging voor Heelkunde. Normering chirurgische behandelingen (Full text: http://www.heelkunde.nl/uploads/qJ/P_/qJP_ Ms0aAh34emgnhD1ePw/NORMEN-2.0.pdf). 2011.